Predicting treatment response using pharmacy register in migraine
نویسندگان
چکیده
منابع مشابه
Predicting treatment response in posttraumatic stress disorder.
Submitted: December 22, 2014; accepted January 5, 2015. Corresponding author: Amit Etkin, MD, PhD, Department of Psychiatry and Behavioral Sciences, Stanford University, 401 Quarry Rd, MC: 5797, Stanford, CA 94305-5797 ([email protected]). J Clin Psychiatry 2015;76(8):e1035–e1036 dx.doi.org/10.4088/JCP.14com09752 © Copyright 2015 Physicians Postgraduate Press, Inc. P stress disorder (PTSD)...
متن کامل[Is a migraine screener useful for pharmacists in community pharmacy to distinguish patients with migraine?].
In this study, to clarify the characteristics of a migraine screener that would be useful to pharmacists in community pharmacies, we used the migraine screener to investigate patients with migraine. Diagnosis of migraine was made according to the internal classification of headache disorders 2nd edition (ICHD-II). Eighty patients with migraine (with aura: n=21, without aura: n=59) were divided ...
متن کاملA large pharmacy claims-based descriptive analysis of patients with migraine and associated pharmacologic treatment patterns
PURPOSE To investigate drug use, prescribing patterns, and comorbidities among patients with migraine in a large pharmacy claims database. METHODS 104,625 migraine subjects (identified according to the criteria in the International Classification of Diseases, Ninth Revision [ICD-9] for migraine or migraine-specific acute medication use) and an equal number of control patients were selected fr...
متن کاملAdvances in migraine treatment.
Migraine is a common, incapacitating disorder that is underdiagnosed in clinical practice. Early and correct diagnosis of migraine is essential and can lead to significant improvements in a patient's quality of life. In the clinical practice setting, a screening tool can be used that can help differentiate migraine from other headache disorders. New research into the development of central sens...
متن کاملNew Mollecules in Migraine Treatment
In the 1990s, serotonin receptor agonist 5-HT1B/1D (the triptans) became available on the market for migraine treatment. Although the triptans are highly effective in aborting migraine attacks, the vasoconstrictor effect in cerebral and coronary territory limits their use. In the “post-triptans” era, new molecules, without vasoactive components are about to expand migraine treatment armamentari...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: The Journal of Headache and Pain
سال: 2019
ISSN: 1129-2369,1129-2377
DOI: 10.1186/s10194-019-0987-y